Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen–positive chronic hepatitis B
2015
Long‐term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus–related cirrhosis
2015
Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis
2016
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France
2016
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Cancer Statistics, 2021
2021 Standout
Molecular diagnosis and treatment of drug-resistant hepatitis B virus
2014
Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
2012
Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA
2014
Cognitive Performance of MDMA-Treated Rhesus Monkeys, Sensitivity to Serotonergic Challenge
2002
Hepatocellular carcinoma
2016 Standout
Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence
1999
Mechanisms of hepatic stellate cell activation
2017 Standout
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Glutamate uptake
2001 Standout
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Ciprofloxacin
1988
Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B
2013
Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis
1999
3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans
1999
Entecavir Treatment for Up to 5 Years in Patients With Hepatitis B E Antigen–Positive Chronic Hepatitis B
2010
Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat
1999
Failure of Inhaled Corticosteroids to Modify Bronchoconstrictor or Bronchodilator Responsiveness in Middle-Aged Smokers with Mild Airflow Obstruction
1992
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
2002 Standout
Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (“Ecstasy”)
2006
Nonresolving pneumonia in steroid-treated patients with obstructive lung disease
1992
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
The efficacy and safety comparison between tenofovir and entecavir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis
2016
Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration
2002
Single-dose Levodopa Administration and Aging Independently Disrupt Time Production
2006
Psychedelics
2016 Standout
Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
2017
Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity
1998
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists
2015
Differential effects of methamphetamine and haloperidol on the control of an internal clock.
2002
Oral Corticosteroid Therapy for Patients with Stable Chronic Obstructive Pulmonary Disease
1991
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease
1993
A review of non-nucleoside anti-hepatitis B virus agents
2014
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naïve Patients With Chronic Hepatitis B
2012
Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking
1999
Double Dissociation of Dopamine Genes and Timing in Humans
2011
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
What makes us tick? Functional and neural mechanisms of interval timing
2005 Standout
Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)
2016
Rationale and Use of Corticosteroids in Chronic Obstructive Pulmonary Disease
1990
Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination
2015
A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration
1999
Portal hypertensive bleeding in cirrhosis
2016 Standout
Tenofovir alafenamide demonstrates broad cross-genotype activity against wild-type HBV clinical isolates and maintains susceptibility to drug-resistant HBV isolates in vitro
2016
Ecstasy (MDMA): a review of its possible persistent psychological effects
2000
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients
2013
MDMA (‘ecstasy’) exhibits an anxiogenic-like activity in social encounters between male mice
2001
Pathophysiological distortions in time perception and timed performance
2011 Standout
Management of treatment failure in chronic hepatitis B
2012
Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task
2009
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Predictors of survival in hepatitis B virus related decompensated cirrhosis on tenofovir therapy: An Indian perspective
2013
Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA‐, α1‐ and 5‐HT2A‐receptors
2002
Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid
2008
Effect of Inhaled Metaproterenol on Exercise Performance in Patients with Stable “Fixed” Airway Obstruction
1988
Impaired Spatial Representation in CA1 after Lesion of Direct Input from Entorhinal Cortex
2008 StandoutNobel
Chronic hepatitis B: Update 2009 #
2009 Standout
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡
2010
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Operant Test Battery Performance in Children
1999
Clinical evidence for the regression of liver fibrosis
2012
Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans
2004
Then and now: The progress in hepatitis B treatment over the past 20 years
2014
Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines
2013
Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure
2016
Hepatitis B virus infection
2018
Cognitive performance amongst recreational users of "ecstasy"
2000
Habit formation and the loss of control of an internal clock: inverse relationship between the level of baseline training and the clock-speed enhancing effects of methamphetamine
2007
Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B
2013
Hepatitis B virus variants
2009
Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
2009
Salivary cortisol in psychoneuroendocrine research: Recent developments and applications
1994 Standout
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
2014
Differential Modulation of Clock Speed by the Administration of Intermittent Versus Continuous Cocaine.
2004
The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
1999
Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
2016
Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the dark agouti rat
2004
MDMA and Learning
2000
Review article: chronic hepatitis B – anti‐viral or immunomodulatory therapy?
2010
Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration
1997
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Glutamate receptor function in learning and memory
2003
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
The option of HBIG-free prophylaxis against recurrent HBV
2012
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
2000 Standout
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
2012
Neurocircuitry of Addiction
2009 Standout
Withdrawal following repeated exposure to d -amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement
1999
A heterogeneous population code for elapsed time in rat medial agranular cortex.
2011
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
2014
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
2010 Standout
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity
2002
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany
2015
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Characterization of behavioral and endocrine effects of LSD on zebrafish
2010
Asthma
2000 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Sputum Eosinophilia Predicts Benefit from Prednisone in Smokers with Chronic Obstructive Bronchitis
1998
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Oxidative Stress in Chronic Obstructive Pulmonary Disease
1997 Standout
Withdrawal of Chronic Systemic Corticosteroids in Patients with COPD
2000
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B
2011
Hepatocellular Carcinoma
2019 Standout
Functional Consequences of Repeated (±)3,4-Methylenedioxymethamphetamine (MDMA) Treatment in Rhesus Monkeys
2001
Genome‐free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy
2014
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
AASLD guidelines for treatment of chronic hepatitis B
2015
Conference
1999
Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance
2013
Chronic Obstructive Pulmonary Disease
1992
Single-dose Levodopa Administration and Aging Independently Disrupt Time Production
2006
Impaired retention of spatial memory after transection of longitudinally oriented axons of hippocampal CA3 pyramidal cells
2002 StandoutNobel
Differential effects of methamphetamine and haloperidol on the control of an internal clock.
2002
The efficacy and safety of entecavir in patients with chronic hepatitis B- associated liver failure: a meta-analysis
2015
Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.
1991
Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory
2003 StandoutNobel
Suboptimal Response to Adefovir Dipivoxil Therapy for Chronic Hepatitis B in Nucleoside-Naive Patients is not due to Pre-Existing Drug-Resistant Mutants
2008
Entecavir plus tenofovir combination therapy in patients with multidrug‐resistant chronic hepatitis B : results of a multicentre, prospective study
2016
Evaluating non-randomised intervention studies
2003 Standout
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial
2015
The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.
2015
Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits
1998
Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta‐analysis
2015
Three Decades of β-Lactamase Inhibitors
2010 Standout
Screening for Hepatitis C Virus Infection in Adolescents and Adults
2020
Meta‐analysis: oral anti‐viral agents in adults with decompensated hepatitis B virus cirrhosis
2012
New developments in antiviral therapy for chronic hepatitis B
2009
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensated and decompensated cirrhotic patients in clinical practice
2013
Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
2017
Review article: long‐term safety of nucleoside and nucleotide analogues in HBV ‐monoinfected patients
2016
The Effects of Morning Naps, Car Trips, and Maternal Separation on Adrenocortical Activity in Human Infants
1991
Entecavir safety and effectiveness in a national cohort of treatment‐naïve chronic hepatitis B patients in the US – the ENUMERATE study
2015
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis
2015
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study
2011
Management of patients with hepatitis B in special populations
2015
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.
2000 Standout
Works of David Frederick being referenced
Safety, efficacy and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to < 18) with chronic hepatitis B
2007
Acute Effects of Dexfenfluramine (d‐FEN) and Methylenedioxymethamphetamine (MDMA) before and after Short‐Course, High‐Dose Treatment
1998
Efficacy and Safety of Long-term Adefovir Dipivoxil Therapy in Children With Chronic Hepatitis B Infection
2012
Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys
1995
Effects of MDMA on Complex Brain Function in Laboratory Animals
1997
The Pharmacokinetics and Safety of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B Virus Infection
2008
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B
2008
Acute behavioral effects of phencyclidine on rhesus monkey performance in an operant test battery
1995
Acute Effects of LSD on Rhesus Monkey Operant Test Battery Performance
1997
Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B
2008
Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection
2010
Acute effects of physostigmine on complex operant behavior in rhesus monkeys
1995
Plasma Levels of Parent Compound and Metabolites after Doses of Either d-Fenfluramine or d-3,4-Methylenedioxymethamphetamine (MDMA) that Produce Long-Term Serotonergic Alterations
2003
Effects of selective dopamine D1- and D2-agonists and antagonists on timing performance in rats
1996
The effects of perinatal hypoxia on the behavioral, neurochemical, and neurohistological toxicity of the metabolic inhibitor 3-nitropropionic acid
1995
Sustained Hepatitis B e Antigen Seroconversion in Patients with Chronic Hepatitis B after Adefovir Dipivoxil Treatment: Analysis of Precore and Basal Core Promoter Mutants
2008
The effects of total and subtotal prefrontal cortex lesions on the timing ability of the rat
1997
76 TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN SUBJECTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL (ADV)
2008
Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis
1986
Acute effects of methylenedioxymethamphetamine (MDMA) on several complex brain functions in monkeys
1995
Corticosteroids in COPD
1986
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
2010
903 TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF (FTC/TDF) FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN PATIENTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL
2009
Hepatitis B Virus e Antigen Loss during Adefovir Dipivoxil Therapy Is Associated with Enhanced Virus-Specific CD4+T-Cell Reactivity
2007
Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment.
1998